Wednesday - September 2, 2026

Pyrrolopyrimidine Amines as Complement Inhibitors

2026-07-14

ALEXANDRIA, Virginia, July 14 -- BIOCRYST PHARMACEUTICALS, INC., Durham, North Carolina has been assigned a patent (No. US 12679843 B2, initially filed April 2, 2021) developed by six inventors Pravin L. Kotian, Hoover, Alabama; Yarlagadda S. Babu, Birmingham, Alabama; Minwan Wu, Vestavia Hills, Alabama; Zhao Dang, Vestavia Hills, Alabama; Trung Xuan Nguyen, Hoover, Alabama; and Krishnan Raman, Birmingham, Alabama, for "Pyrrolopyrimidine amines as complement inhibitors." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Pyrrolopyrimidine Amines as Complement Inhibitors

Information Request Form

Copyright Targeted News Service 2026